The insulin-like growth factor mutation database (IGFmdb)

Growth Hormone and IGF Research

Volumn 22, Issue 5, 2012, Pages 158-166

  Rajapaksha, Harinda ^a   Alvino, Clair ^a   McCarthy, Peter ^a   Forbes, Briony E ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Binding affinity; IGF I; IGF II; IGFBP; Insulin; Insulin receptor; Insulin like growth factor; Mutation database; Type 1 insulin like growth factor receptor; Type 2 insulin like growth factor receptor

Indexed keywords

INSULIN DERIVATIVE; ISOPROTEIN; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN C; SOMATOMEDIN C DERIVATIVE; SOMATOMEDIN C RECEPTOR;

ACCESS TO INFORMATION; ARTICLE; BINDING SITE; CELL MIGRATION; COMPUTER MODEL; GENETIC DATABASE; LIGAND BINDING; MOLECULAR INTERACTION; MUTATIONAL ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROTEIN DATABASE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RECEPTOR AFFINITY; RECEPTOR BINDING; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS;

DATABASES, FACTUAL; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; LIGANDS; MUTATION; SOMATOMEDINS;

EID: 84865396609     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2012.05.001     Document Type: Article

References (51)

1. Rosenfeld R.G., Belgorosky A., Camacho-Hubner C., Savage M.O., Wit J.M., Hwa V. Defects in growth hormone receptor signaling. Trends Endocrinol. Metab. 2007, 18:134-141.
2. Laron Z. Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958-2003. J. Clin. Endocrinol. Metab. 2004, 89:1031-1044.
3. Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat. Rev. Cancer 2008, 8:915-928.
4. Ward C.W., Lawrence M.C. Ligand-induced activation of the insulin receptor: a multi-step process involving structural changes in both the ligand and the receptor. Bioessays 2009, 31:422-434.
5. Denley A., Cosgrove L.J., Booker G.W., Wallace J.C., Forbes B.E. Molecular interactions of the IGF system. Cytokine Growth Factor Rev. 2005, 16:421-439.
6. Forbes B.E., McCarthy P., Norton R.S. Insulin-like growth factor binding proteins: a structural perspective. Front. Endocrin. 2012, 3(38):1-13.
7. Boisclair Y.R., Rhoads R.P., Ueki I., Wang J., Ooi G.T. The acid-labile subunit (ALS) of the 150kDa IGF-binding protein complex: an important but forgotten component of the circulating IGF system. J. Endocrinol. 2001, 170:63-70.
8. De Meyts P., Whittaker J. Structural biology of insulin and IGF1 receptors: implications for drug design. Nat. Rev. Drug Discov. 2002, 1:769-783.
9. Ghosh P., Dahms N.M., Kornfeld S. Mannose 6-phosphate receptors: new twists in the tale. Nat. Rev. Mol. Cell Biol. 2003, 4:202-212.
10. Brown J., Jones E.Y., Forbes B.E. Interactions of IGF-II with the IGF2R/cation-independent mannose-6-phosphate receptor mechanism and biological outcomes. Vitam. Horm. 2009, 80:699-719.
11. Brown J., Jones E.Y., Forbes B.E. Keeping IGF-II under control: lessons from the IGF-II-IGF2R crystal structure. Trends Biochem. Sci. 2009, 34:612-619.
12. Seino S., Bell G.I. Alternative splicing of human insulin receptor messenger RNA. Biochem. Biophys. Res. Commun. 1989, 159:312-316.
13. Denley A., Wallace J.C., Cosgrove L.J., Forbes B.E. The insulin receptor isoform exon 11- (IR-A) in cancer and other diseases: a review. Horm. Metab. Res. 2003, 35:778-785.
14. Frasca F., Pandini G., Scalia P., et al. Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol. Cell. Biol. 1999, 19:3278-3288.
15. Slaaby R., Schaffer L., Lautrup-Larsen I., et al. Hybrid receptors formed by insulin receptor (IR) and insulin-like growth factor I receptor (IGF-IR) have low insulin and high IGF-1 affinity irrespective of the IR splice variant. J. Biol. Chem. 2006, 281:25869-25874.
16. De Meyts P. Insulin and its receptor: structure, function and evolution. Bioessays 2004, 26:1351-1362.
17. McKern N.M., Lawrence M.C., Streltsov V.A., et al. Structure of the insulin receptor ectodomain reveals a folded-over conformation. Nature 2006, 443:218-221.
18. Smith B.J., Huang K., Kong G., et al. Structural resolution of a tandem hormone-binding element in the insulin receptor and its implications for design of peptide agonists. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:6771-6776.
19. Kiselyov V.V., Versteyhe S., Gauguin L., De Meyts P. Harmonic oscillator model of the insulin and IGF1 receptors' allosteric binding and activation. Mol. Syst. Biol. 2009, 5:1-12.
20. Vashisth H., Abrams C.F. All-atom structural models for complexes of insulin-like growth factors IGF1 and IGF2 with their cognate receptor. J. Mol. Biol. 2010, 400:645-658.
21. Vashisth H., Abrams C.F. Docking of insulin to a structurally equilibrated insulin receptor ectodomain. Proteins 2010, 78:1531-1543.
22. Sajid W., Holst P.A., Kiselyov V.V., et al. Structural basis of the aberrant receptor binding properties of hagfish and lamprey insulins. Biochemistry 2009, 48:11283-11295.
23. Conlon J.M. Evolution of the insulin molecule: insights into structure-activity and phylogenetic relationships. Peptides 2001, 22:1183-1193.
24. Bayne M.L., Applebaum J., Chicchi G.G., Hayes N.S., Green B.G., Cascieri M.A. Structural analogs of human insulin-like growth factor I with reduced affinity for serum binding proteins and the type 2 insulin-like growth factor receptor. J. Biol. Chem. 1988, 263:6233-6239.
25. Bayne M.L., Applebaum J., Underwood D., et al. The C region of human insulin-like growth factor (IGF) I is required for high affinity binding to the type 1 IGF receptor. J. Biol. Chem. 1989, 264:11004-11008.
26. Sakano K., Enjoh T., Numata F., et al. The design, expression, and characterization of human insulin-like growth factor II (IGF-II) mutants specific for either the IGF-II/cation-independent mannose 6-phosphate receptor or IGF-I receptor. J. Biol. Chem. 1991, 266:20626-20635.
27. Alvino C.L., McNeil K.A., Ong S.C., et al. A novel approach to identify two distinct receptor binding surfaces of insulin-like growth factor II. J. Biol. Chem. 2009, 284:7656-7664.
28. Gauguin L., Delaine C., Alvino C.L., et al. Alanine scanning of a putative receptor binding surface of insulin-like growth factor-I. J. Biol. Chem. 2008, 283:20821-20829.
29. Gauguin L., Klaproth B., Sajid W., et al. Structural basis for the lower affinity of the insulin-like growth factors for the insulin receptor. J. Biol. Chem. 2008, 283:2604-2613.
30. Delaine C., Alvino C.L., McNeil K.A., et al. A novel binding site for the human insulin-like growth factor-II (IGF-II)/mannose 6-phosphate receptor on IGF-II. J. Biol. Chem. 2007, 282:18886-18894.
31. Brown J., Delaine C., Zaccheo O.J., et al. Structure and functional analysis of the IGF-II/IGF2R interaction. EMBO J. 2008, 27:265-276.
32. Forbes B.E. Molecular mechanisms underlying insulin-like growth factor action: how mutations in the GH: IGF axis lead to short stature. Pediatr. Endocrinol. Rev. 2011, 8:374-381.
33. Denley A., Wang C.C., McNeil K.A., et al. Structural and functional characteristics of the Val44Met insulin-like growth factor I missense mutation: correlation with effects on growth and development. Mol. Endocrinol. 2005, 19:711-721.
34. Netchine I., Azzi S., Houang M., et al. Partial primary deficiency of insulin-like growth factor (IGF)-I activity associated with IGF1 mutation demonstrates its critical role in growth and brain development. J. Clin. Endocrinol. Metab. 2009, 94:3913-3921.
35. den Dunnen J.T., Antonarakis S.E. Nomenclature for the description of human sequence variations. Hum. Genet. 2001, 109:121-124.
36. Schaffer M.L., Deshayes K., Nakamura G., Sidhu S., Skelton N.J. Complex with a phage display-derived peptide provides insight into the function of insulin-like growth factor I. Biochemistry 2003, 42:9324-9334.
37. Torres A.M., Forbes B.E., Aplin S.E., Wallace J.C., Francis G.L., Norton R.S. Solution structure of human insulin-like growth factor II. Relationship to receptor and binding protein interactions. J. Mol. Biol. 1995, 248:385-401.
38. Sitar T., Popowicz G.M., Siwanowicz I., Huber R., Holak T.A. Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:13028-13033.
39. McKinnon T., Chakraborty C., Gleeson L.M., Chidiac P., Lala P.K. Stimulation of human extravillous trophoblast migration by IGF-II is mediated by IGF type 2 receptor involving inhibitory G protein(s) and phosphorylation of MAPK. J. Clin. Endocrinol. Metab. 2001, 86:3665-3674.
40. Gallicchio M.A., Kaun C., Wojta J., Binder B., Bach L.A. Urokinase type plasminogen activator receptor is involved in insulin-like growth factor-induced migration of rhabdomyosarcoma cells in vitro. J. Cell. Physiol. 2003, 197:131-138.
41. Roth B.V., Burgisser D.M., Luthi C., Humbel R.E. Mutants of human insulin-like growth factor II: expression and characterization of analogs with a substitution of TYR27 and/or a deletion of residues 62-67. Biochem. Biophys. Res. Commun. 1991, 181:907-914.
42. Minniti C.P., Kohn E.C., Grubb J.H., et al. The insulin-like growth factor II (IGF-II)/mannose 6-phosphate receptor mediates IGF-II-induced motility in human rhabdomyosarcoma cells. J. Biol. Chem. 1992, 267:9000-9004.
43. Maeng Y.S., Choi H.J., Kwon J.Y., et al. Endothelial progenitor cell homing: prominent role of the IGF2-IGF2R-PLCbeta2 axis. Blood 2009, 113:233-243.
44. El-Shewy H.M., Lee M.H., Obeid L.M., Jaffa A.A., Luttrell L.M. The insulin-like growth factor type 1 and insulin-like growth factor type 2/mannose-6-phosphate receptors independently regulate ERK1/2 activity in HEK293 cells. J. Biol. Chem. 2007, 282:26150-26157.
45. El-Shewy H.M., Abdel-Samie S.A., Al Qalam A.M., et al. Phospholipase C and protein kinase C-beta 2 mediate insulin-like growth factor II-dependent sphingosine kinase 1 activation. Mol. Endocrinol. 2011, 25:2144-2156.
46. Cyster J.G. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu. Rev. Immunol. 2005, 23:127-159.
47. Oh Y., Muller H.L., Zhang H., Ling N., Rosenfeld R.G. Synthesis and characterization of IGF-II analogs: applications in the evaluation of IGF receptor function and IGF-independent actions of IGFBPs. Adv. Exp. Med. Biol. 1993, 343:41-54.
48. Francis G.L., Aplin S.E., Milner S.J., McNeil K.A., Ballard F.J., Wallace J.C. Insulin-like growth factor (IGF)-II binding to IGF-binding proteins and IGF receptors is modified by deletion of the N-terminal hexapeptide or substitution of arginine for glutamate-6 in IGF-II. Biochem. J. 1993, 293:713-719.
49. Bach L.A., Hsieh S., Sakano K., Fujiwara H., Perdue J.F., Rechler M.M. Binding of mutants of human insulin-like growth factor II to insulin-like growth factor binding proteins 1-6. J. Biol. Chem. 1993, 268:9246-9254.
50. Headey S.J., Keizer D.W., Yao S., Wallace J.C., Bach L.A., Norton R.S. Binding site for the C-domain of insulin-like growth factor (IGF) binding protein-6 on IGF-II; implications for inhibition of IGF actions. FEBS Lett. 2004, 568:19-22.
51. Hua Q.X., Gozani S.N., Chance R.E., Hoffmann J.A., Frank B.H., Weiss M.A. Structure of a protein in a kinetic trap. Nat. Struct. Biol. 1995, 2:129-138.